Book contents
- Treatment of Dystonia
- Treatment of Dystonia
- Copyright page
- Contents
- Contributors
- Preface
- 1 Development of the Concept of Dystonia as a Disease, a Syndrome and a Movement Phenomenology
- Section I Basics
- Section II Botulinum Toxin Therapy
- 21 The Global Market for Botulinum Toxin
- 22 Molecular Mechanisms of Botulinum Toxin
- 23 Indirect Central Nervous System Effects of Botulinum Toxin
- 24 Direct Central Nervous System Effects of Botulinum Neurotoxin
- 25 Analgesic Effects of Botulinum Toxins
- 26 Manufacture of Commercial Botulinum Neurotoxins for Human Treatment
- 27 Pharmacology of Botulinum Toxins
- 28 Immunology of Botulinum Toxin Therapy
- 29 Use of Non-A/Non-B Botulinum Toxins
- 30 Clinical Muscular Anatomy for the Botulinum Toxin Injector
- 31 Ultrasound Guidance for Botulinum Toxin Application
- 32 Treatment Algorithms and Injection Schemes for Botulinum Toxin Therapy of Dystonia
- 33 Botulinum Toxin Therapy for Cervical Dystonia
- 34 Botulinum Toxin Therapy for Cranial Dystonia
- 35 Botulinum Toxin Therapy for Spasmodic Dysphonia
- 36 Botulinum Toxin Therapy for Writer’s Cramp and Other Focal Hand Dystonias
- 37 Botulinum Toxin Therapy for Bruxism
- 38 Treatment of Blepharospasm With Eyelid-Opening Apraxia
- 39 Organisation of a Botulinum Toxin Clinic
- Section III Musician’s Dystonia
- Section IV Psychogenic Dystonia
- Section V Treatment of Paediatric Dystonia
- Section VI Rehabilitation of Dystonia
- Section VII Pharmacotherapy for Dystonia
- Section VIII Surgical Treatment of Dystonia
- Section IX Deep Brain Stimulation for Dystonia
- Section X Emerging Therapies for Dystonia
- Section XI Future Trends in Dystonia Therapy
- Book part
- Index
- References
37 - Botulinum Toxin Therapy for Bruxism
from Section II - Botulinum Toxin Therapy
Published online by Cambridge University Press: 31 May 2018
By
Book contents
- Treatment of Dystonia
- Treatment of Dystonia
- Copyright page
- Contents
- Contributors
- Preface
- 1 Development of the Concept of Dystonia as a Disease, a Syndrome and a Movement Phenomenology
- Section I Basics
- Section II Botulinum Toxin Therapy
- 21 The Global Market for Botulinum Toxin
- 22 Molecular Mechanisms of Botulinum Toxin
- 23 Indirect Central Nervous System Effects of Botulinum Toxin
- 24 Direct Central Nervous System Effects of Botulinum Neurotoxin
- 25 Analgesic Effects of Botulinum Toxins
- 26 Manufacture of Commercial Botulinum Neurotoxins for Human Treatment
- 27 Pharmacology of Botulinum Toxins
- 28 Immunology of Botulinum Toxin Therapy
- 29 Use of Non-A/Non-B Botulinum Toxins
- 30 Clinical Muscular Anatomy for the Botulinum Toxin Injector
- 31 Ultrasound Guidance for Botulinum Toxin Application
- 32 Treatment Algorithms and Injection Schemes for Botulinum Toxin Therapy of Dystonia
- 33 Botulinum Toxin Therapy for Cervical Dystonia
- 34 Botulinum Toxin Therapy for Cranial Dystonia
- 35 Botulinum Toxin Therapy for Spasmodic Dysphonia
- 36 Botulinum Toxin Therapy for Writer’s Cramp and Other Focal Hand Dystonias
- 37 Botulinum Toxin Therapy for Bruxism
- 38 Treatment of Blepharospasm With Eyelid-Opening Apraxia
- 39 Organisation of a Botulinum Toxin Clinic
- Section III Musician’s Dystonia
- Section IV Psychogenic Dystonia
- Section V Treatment of Paediatric Dystonia
- Section VI Rehabilitation of Dystonia
- Section VII Pharmacotherapy for Dystonia
- Section VIII Surgical Treatment of Dystonia
- Section IX Deep Brain Stimulation for Dystonia
- Section X Emerging Therapies for Dystonia
- Section XI Future Trends in Dystonia Therapy
- Book part
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Treatment of Dystonia , pp. 182 - 184Publisher: Cambridge University PressPrint publication year: 2018
References
Carrillo, RJC (2011). Pterygoid botulinum toxin injection. Philipp J Otolaryngol Head Neck Surg 26:55–56.CrossRefGoogle Scholar
Ernberg, M, Hedenberg-Magnusson, B, List, T, Svensson, P (2011). Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study. Pain 152:1988–1996.CrossRefGoogle Scholar
Frisardi, G, Iani, C, Sau, G, Frisardi, F, Leornadis, C, Lumbau, A, Enrico, P, Sirca, D, Staderini, EM, Chessa, G (2013). A relationship between bruxism and orofacial dystonia? A trigeminal electrophysiological approach in a case report of pineal cavernoma. Behav Brain Funct 9:41.Google Scholar
Gjovreku, E, Vyshka, G (2013). Nocturnal bruxism: still a nosological conundrum? WebmedCentral Dentistry 4(5):WMC004234.Google Scholar
Guarda-Nardini, L, Manfredini, D, Salamone, M, Salmaso, L, Tonello, S, Ferronato, G (2008). Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study. Cranio 26:126–135.Google Scholar
Laine, CM, Yavuz, ŞU, D’Amico, JM, Gorassini, MA, Türker, KS, Farina, D (2015). Jaw tremor as a physiological biomarker of bruxism. Clin Neurophysiol 126:1746–1753.CrossRefGoogle ScholarPubMed
Lee, SJ, McCall, WD, Kim, YK, Chung, SC, Chung, JW (2010). Effect of botulinum toxin injection on nocturnal bruxism: a randomized controlled trial. Am J Phys Med Rehabil 89:16–23.CrossRefGoogle ScholarPubMed
Long, H, Liao, Z, Wang, Y, Liao, L, Lai, W (2012). Efficacy of botulinum toxins on bruxism: an evidence-based review. Int Dent J 62:1–5.CrossRefGoogle ScholarPubMed
Mor, N, Tang, C, Blitzer, A (2015). Temporomandibular myofascial pain treated with botulinum toxin injection. Toxins 7:2791–2800.CrossRefGoogle Scholar
Murray, GM, Phanachet, I, Uchida, S, Whittle, T (2001). The role of the human lateral pterygoid muscle in the control of horizontal jaw movements. J Orofac Pain 15: 279–292; discussion 292–305.Google ScholarPubMed
Nayyar, P, Kumar, P, Nayyar, PV, Singh, A (2014). Botox: broadening the horizon of dentistry. J Clin Diagn Res 8:ZE25–ZE29.Google ScholarPubMed
Onodera, K, Sato, S (2008). Bruxism evaluating sheet. United States Patent Application: 20080211123. www.freepatentsonline.com/y2008/0211123.html (accessed 11 October 2016).Google Scholar
Orlova, O, Soikher, MI, Soikher, MG, Mingazova, L, Kotlyarov, V, Slavicek, G (2010). Therapeutic application of botulinum toxin A in patients with local muscle dystonia and oral dyskinesia. J Stomat Occ Med 3:23–28.CrossRefGoogle Scholar
Persaud, R, Garas, G, Silva, S, Stamatoglou, C, Chatrath, P, Patel, K (2013). An evidence-based review of botulinum toxin (Botox) applications in non-cosmetic head and neck conditions. JRSM Short Rep 4:10.Google Scholar
Shim, YJ, Lee, MK, Kato, T, Park, HU, Heo, K, Kim, ST (2014). Effects of botulinum toxin on jaw motor events during sleep in sleep bruxism patients: a polysomnographic evaluation. J Clin Sleep Med 10: 291–298.CrossRefGoogle ScholarPubMed
Sposito, M, Teixeira, S (2014). Botulinum toxin A for bruxism: a systematic review. Acta Fisiatr 21:201–204.CrossRefGoogle Scholar
Tintner, R, Jankovic, J (2002). Botulinum toxin type A in the management of oromandibular dystonia and bruxism. In: Brin, MF, Hallett, M, J (Eds), Jankovic. Scientific and Therapeutic Aspects of Botulinum Toxin. Lippincott Williams & Wilkins, Philadelphia, PA.Google Scholar